Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Dacomitinib impurity 8 is a chemical impurity associated with the pharmacological compound Dacomitinib, a targeted therapy for non-small cell lung cancer. This impurity can be utilized in analytical research to assess the purity and stability of Dacomitinib formulations. Understanding such impurities is critical for ensuring the quality and efficacy of therapeutic agents in drug development. -
Drug Impurity
Plesafo impurity 2 is identified as a drug impurity associated with Plesafo. This compound serves as a critical reference standard for analytical applications, including method validation and quality control in pharmaceutical development. Its characterization is essential for assessing the purity and safety profiles of drug formulations containing Plesafo. -
Drug Impurity
Mycophenolate impurity 2 is a chemical byproduct associated with the synthesis of Mycophenolate. As a drug impurity, it serves as an important reference standard in analytical chemistry for the evaluation of purity and stability in pharmaceutical formulations. It is commonly utilized in research applications focused on drug development and quality control testing to ensure the integrity and safety of Mycophenolate-containing products. -
Drug Impurity
Atorvastatin impurity 5 is a known impurity associated with the cholesterol-lowering agent Atorvastatin. This compound can be utilized for quality control and analytical studies in pharmaceutical research, particularly in the assessment of drug purity and stability. Its identification and quantification are essential for ensuring the efficacy and safety of Atorvastatin formulations. -
Drug Impurity
Aripiprazole impurity 11 is a chemical impurity associated with the antipsychotic agent Aripiprazole. This compound serves as an essential reference standard for the evaluation of drug purity and quality control in pharmaceutical research. Its characterization is crucial for assessing the safety and efficacy of Aripiprazole formulations. -
Drug Impurity
Sofosbuvir impurity 2 is a characterized impurity of Sofosbuvir, a nucleotide analog antiviral agent targeting the hepatitis C virus. This impurity serves as a crucial reference standard for quality control and stability studies in pharmaceutical research and development. Its identification and quantification are essential for ensuring the integrity of Sofosbuvir formulations. -
Drug Impurity
Fluphenazine decanoate impurity 10 is a chemical impurity associated with Fluphenazine decanoate. This compound is primarily utilized in the quality control and characterization of pharmaceutical formulations, as it provides insight into the purity and stability of the parent drug. Research applications may include studies on drug metabolism, efficacy, and safety in the context of antipsychotic therapy. -
Drug Impurity
Tamsulosin impurity 7 is a known impurity associated with the pharmaceutical agent Tamsulosin, a selective α1-adrenergic antagonist. This compound is utilized primarily in the analysis of drug purity and stability within pharmaceutical research. Its presence can be important for understanding the quality control and regulatory compliance of Tamsulosin formulations. -
Drug Impurity
Mebendazole Impurity 1, also known as 1-Methylpiperazine 1-oxide, is a chemical impurity associated with Mebendazole. This compound is relevant in ensuring the quality and safety of pharmaceutical formulations containing Mebendazole. Its analysis and characterization are essential in drug development and quality control processes within pharmaceutical research. -
Drug Impurity
Abiraterone Impurity 10 is a chemical impurity associated with the drug Abiraterone, which works by inhibiting the enzyme CYP17A1, thereby reducing androgen production. This compound serves as a crucial reference material for quality control and analytical validation in pharmaceutical research. Its characterization is essential for ensuring the purity and efficacy of Abiraterone formulations in clinical applications. -
Drug Impurity
Clarithromycin impurity 9 is a known impurity associated with the antibiotic clarithromycin. This compound is primarily utilized in analytical chemistry for the identification and quantification of drug impurities in pharmaceutical formulations. Research applications include the assessment of drug quality and the evaluation of metabolic pathways in drug development. -
Drug Impurity
Haloperidol impurity 4, also known as Haloperidol impurity E, is a chemical impurity associated with Haloperidol. It serves as a crucial reference standard for quality control and analytical studies in pharmaceutical research. The identification and characterization of this impurity are important for ensuring the purity and safety of Haloperidol formulations in drug development and pharmacokinetic studies. -
Drug Intermediate
4-Biphenylthio carboxamide is a synthetic compound utilized primarily as a drug intermediate in pharmaceutical synthesis. This compound serves as a critical building block for the development of various bioactive molecules. Its versatility allows for use in diverse applications within medicinal chemistry and drug discovery. -
Drug Impurity
Rebamipide impurity 2 is a chemical impurity associated with Rebamipide. It serves as a reference standard for quality control and the assessment of purity in pharmaceutical formulations. This reagent is critical for researchers conducting studies related to the synthesis and characterization of Rebamipide, facilitating accurate analytics in drug development and regulatory compliance. -
Drug Impurity
Lipoic acid impurity 1 is a chemical byproduct associated with Lipoic acid. Its characterization is critical for quality control in pharmaceutical formulations. As a drug impurity, it is studied for its potential effects on the efficacy and safety profiles of lipoic acid-based therapies. This compound plays a role in ensuring regulatory compliance and optimizing therapeutic strategies in research applications. -
Drug Impurity
Azilsartan impurity 25 is characterized as a drug impurity of Azilsartan, an angiotensin II receptor antagonist. This impurity may serve as a key reference standard in the assessment of Azilsartan's purity and can be utilized in method development and validation during pharmaceutical research. It is essential for ensuring compliance with regulatory standards in drug formulation and quality control. -
Drug Impurity
Ondansetron impurity 5 is a structural impurity of the antiemetic agent Ondansetron. Its characterization is critical for pharmacological and toxicological studies, ensuring the safety and efficacy profiles of Ondansetron formulations. This compound serves as a reference standard in quality control and analytical research, facilitating the assessment of drug purity and compliance with regulatory standards. -
Drug Impurity
Trimetazidine impurity 4 is a known impurity associated with the antiischemic agent Trimetazidine. This compound serves as a reference standard for the analysis of pharmaceutical formulations and quality control processes. Its identification and quantification are essential for ensuring the purity of Trimetazidine in drug development and regulatory compliance. -
Drug Intermediate
(1R,3R)-3-Benzoic acid 3-carboxycyclopentyl ester serves as a critical drug intermediate with applications in the synthesis of various pharmaceuticals. Its structure facilitates the development of bioactive compounds by providing a unique bicyclic framework. This reagent supports research in medicinal chemistry, particularly in the design and assembly of complex organic molecules. -
Drug Impurity
Sildenafil impurity 8 is a chemical impurity associated with the synthesis of Sildenafil, a potent phosphodiesterase type 5 (PDE5) inhibitor. This impurity is utilized in analytical research to ensure the quality and purity of Sildenafil formulations. Its identification and quantification are essential for regulatory compliance and therapeutic efficacy assessments in pharmaceutical development. -
Drug Impurity
Linagliptin impurity 9 is a recognized impurity associated with the DPP-4 inhibitor Linagliptin. This compound serves as a critical reference standard for analytical methods in quality control and stability testing of Linagliptin formulations. Its identification and quantification are essential for ensuring the purity and safety of pharmaceutical products. -
Drug Impurity
Montelukast Impurity 9 is a characterized impurity of Montelukast, a leukotriene receptor antagonist. This compound is utilized primarily in research settings to assess the purity and quality of Montelukast formulations. Its presence can impact the pharmacological effectiveness and safety profile of the primary drug, making it essential for analytical studies and drug development processes. -
Drug Impurity
Trazodone impurity 4 is a known impurity of the antidepressant Trazodone. This compound serves as a vital analytical standard for evaluating the purity and quality of Trazodone formulations. It is utilized in pharmaceutical research, quality control, and method development to ensure compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Progesterone impurity D is characterized as an impurity of the steroid hormone progesterone. This compound is relevant in the assessment of drug quality and purity in pharmaceutical formulations containing progesterone. Its presence may affect the overall efficacy and safety profile of hormone-related therapies, making it important for quality control in research and development settings. -
Drug Impurity
Bortezomib impurity 12 is a known impurity of the proteasome inhibitor Bortezomib, which targets the 26S proteasome and plays a crucial role in the degradation of ubiquitinated proteins. This compound is significant in pharmaceutical research for assessing the purity and quality of Bortezomib formulations, ensuring compliance with regulatory standards. Its presence is critical in understanding the safety and efficacy profiles of drug products containing Bortezomib. -
Drug Impurity
Paliperidone impurity 9 hydrochloride is a chemical byproduct associated with Paliperidone hydrochloride, which primarily acts as an atypical antipsychotic agent targeting dopamine D2 receptors. This impurity is relevant for analytical chemistry and pharmacological development, particularly in ensuring the purity and quality of Paliperidone formulations. Research applications include stability studies, method validation, and toxicological assessments related to pharmaceutical compounds. -
Drug Impurity
Mesalazine impurity 4 is a chemical impurity associated with Mesalazine, a drug primarily used in the treatment of inflammatory bowel disease. This impurity serves as a critical reference standard for quality control and analytical purposes in pharmaceutical research. Its presence in formulations can influence efficacy and safety profiles, making it essential for thorough analytical studies on Mesalazine and related compounds. -
Drug Impurity
Trazodone impurity 5 is a known impurity associated with the antidepressant Trazodone. This compound serves as a standard reference for pharmaceutical quality control, enabling the assessment of purity and verification of synthesis processes. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Atenolol impurity 10 is a known impurity of the beta-adrenergic blocker Atenolol. This compound serves as an important tool for quality control and analytical studies, aiding in the assessment of drug purity and stability. Its presence can influence pharmacokinetics and dosing regimens, making it valuable in pharmaceutical development and regulatory compliance assessments. Researchers can utilize this impurity for method validation and impurity profiling in Atenolol formulations. -
Drug Impurity
Methylprednisolone impurity 2 is identified as a chemical impurity associated with Methylprednisolone. This compound serves as an important analytical reference standard in evaluating the purity of Methylprednisolone formulations. It is utilized in various research applications, including pharmacokinetics studies and stability testing, to ensure the quality and safety of pharmaceutical products. -
Drug Impurity
Haloperidol impurity 7, also known as Haloperidol N-oxide, is a drug impurity associated with the antipsychotic agent Haloperidol. Its presence may influence both pharmacological activity and safety profiles in various formulations. This compound is primarily analyzed in the context of quality control and regulatory compliance in pharmaceutical research. Additionally, it serves as a reference standard for the identification and quantification of impurities in Haloperidol production. -
Drug Intermediate Control
(1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the development of bioactive molecules, contributing to research in medicinal chemistry and drug formulation. Its structural characteristics make it an essential reagent for the synthesis of various therapeutic agents. -
Drug Impurity
Rosuvastatin impurity 23 is a drug impurity associated with the statin medication Rosuvastatin, which targets HMG-CoA reductase. This compound is primarily used in pharmaceutical research to assess the purity and quality of Rosuvastatin formulations, ensuring compliance with regulatory standards. Its characterization is vital for studies focused on the safety and pharmacokinetics of statin therapies. -
Drug Impurity
Terbinafine impurity 4 is a known impurity of the antifungal agent Terbinafine. It is primarily used in analytical research to assess the purity and quality of Terbinafine formulations. This compound can facilitate the study of drug stability, degradation pathways, and the identification of potential side effects related to impurities in drug development and manufacturing processes. -
Drug Impurity
Afatinib impurity 32 is a characterized impurity of Afatinib, a selective inhibitor of the ErbB family of receptor tyrosine kinases. This compound is primarily utilized in the quality control and analytical studies related to Afatinib production. Its presence can provide insight into the synthetic pathway and aid in ensuring the purity and potency of the final drug product. -
Drug Impurity
Cetirizine Impurity 14 is a chemical compound classified as a drug impurity associated with the antihistamine cetirizine. This impurity may play a role in assessing the purity and stability of cetirizine formulations during pharmaceutical development. Its presence can provide insights into the synthesis process and help in regulatory compliance for drug quality control. -
Drug Impurity
Clindamycin palmitate impurity 6 (Clindamycin B palmitate) is a drug impurity characterized by its specific structural modifications to clindamycin. It serves as a quality control standard in the analysis of clindamycin formulations to ensure safety and efficacy. This compound is relevant for researchers investigating drug purity and the effects of impurities on biological activity and pharmacokinetics. -
Drug Impurity
Solifenacin impurity 6, a known impurity of Solifenacin, serves as a critical reagent for analytical chemistry applications. This compound is essential for ensuring the purity and safety of Solifenacin formulations during quality control processes. Its characterization and quantification are vital in pharmacological studies and regulatory assessments, contributing to the overall understanding of Solifenacin's chemical profile. -
Drug Impurity
Acyclovir impurity 3, also known as Acyclovir N-methylene dimer, is a drug impurity associated with Acyclovir synthesis. Its presence in pharmaceutical formulations can influence the safety and efficacy profiles of Acyclovir. This compound is utilized in stability studies and quality control assessments to ensure the purity of drug formulations in research and development settings. -
Drug Impurity
Lornoxicam impurity 16 serves as a recognized impurity of Lornoxicam, a non-steroidal anti-inflammatory drug (NSAID). Its characterization is crucial for assessing the purity and safety profiles of pharmaceutical formulations containing Lornoxicam. This compound is utilized in research applications focusing on drug formulation development and quality control within the pharmaceutical industry. -
Drug Impurity
Olaparib impurity 22 is a characterized impurity of the PARP inhibitor Olaparib. This compound is essential for quality control and analytical studies in drug development, particularly in assessing the purity and stability of Olaparib formulations. Its presence can influence therapeutic efficacy and safety profiles, making it a critical reagent for researchers investigating PARP inhibition in cancer therapy. -
Drug Impurity
Everolimus impurity 11 is a chemical impurity associated with the mTOR inhibitor Everolimus. This impurity is essential for evaluating the quality and stability of Everolimus formulations in pharmaceutical research. It plays a crucial role in ensuring compliance with regulatory standards and understanding the compound's behavior in biological systems. Researchers may utilize this impurity for analytical characterization and to study its potential effects on mTOR signaling pathways. -
Drug Impurity
Apixaban impurity 14 is a known impurity associated with Apixaban, an anticoagulant used for the prevention of thromboembolic events. This reagent can be utilized to assess the purity of Apixaban formulations and support quality control measures in pharmaceutical development. Its detection and characterization are critical for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Aripiprazole impurity 3 is a synthetic byproduct associated with the antipsychotic agent Aripiprazole. This compound serves as a valuable tool for quality control and analysis in pharmaceutical research, particularly in the development and purification processes of Aripiprazole. Its characterization aids in ensuring the safety and efficacy of formulations containing the active drug. -
Drug Impurity
Flecainide Impurity 2 is a known impurity of the antiarrhythmic agent Flecainide. This compound serves as a reference standard for the quality control and characterization of Flecainide formulations. Its identification and quantification are critical in ensuring the purity and consistency of pharmaceutical products containing Flecainide, making it essential for research and development in medicinal chemistry and analytical chemistry applications. -
Drug Impurity
Azithromycin impurity 1 is a recognized impurity variant of the antibiotic Azithromycin. This compound serves as a critical reference standard for quality control and analytical testing in drug formulation. Its characterization is essential for ensuring the purity and efficacy of Azithromycin in pharmaceutical applications and contributes to the understanding of its stability and degradation pathways. -
Drug Impurity
Ranitidine impurity 8 is a recognized impurity associated with the drug Ranitidine. It serves as a critical reference standard for the analytical evaluation of Ranitidine formulations, ensuring compliance with regulatory specifications. This compound is essential for quality control and stability testing in pharmaceutical research, providing valuable insights into the drug's purity and safety profile. -
Drug Impurity
Trazodone Impurity 8 is a synthetic impurity associated with the drug Trazodone, primarily a serotonin antagonist and reuptake inhibitor. This compound is utilized in research to study the pharmacological effects and safety profiles of Trazodone, aiding in the assessment of drug quality and compliance in pharmaceutical formulations. Its presence can provide insights into metabolic pathways and potential side effects, making it valuable for drug development and regulatory analysis. -
Drug Impurity
Diclofenac impurity 5 is a chemical impurity associated with Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID). This impurity can be of interest in pharmacokinetic studies and quality control processes due to its potential effects on the drug's safety and efficacy. Research applications include analysis of drug formulations, stability testing, and assessment of the impurity's impact on pharmacological activity. -
Drug Impurity
Abacavir impurity 5, known as trans-Abacavir Hydrochloride, is a specific impurity associated with the antiviral medication Abacavir. It is primarily used in pharmaceutical research and quality control to ensure the purity and safety of Abacavir formulations. This compound serves as a reference standard for the analysis and identification of impurities in drug development processes.
